News

pureLiFi offers IT reseller opportunity

For the first time, TRICAPITAL investee pureLiFi is making its LiFi-XC system available to IT resellers, to augment and enhance their networking and wireless portfolio.

IT professionals often labour over undependable Wi-Fi networks, and are perpetually implementing new ways to secure these vulnerable connections.

LiFi is a game changer in connectivity that offers high speed, reliable and inherently secure wireless communications, by simply using light.

What is LiFi?

LiFi is the use of light to transmit data without using radio frequencies like Wi-Fi. With LiFi light becomes the carrier of data allowing for high speed, inherently secure connectivity anywhere there is illumination.


Find out about the pureLiFi reseller opportunity.

For more information about the company, visit the pureLiFi website.

My1Login scoops industry awards

It’s been a fantastic few months for TRICAPITAL investee My1Login, with the company picking up a number of industry awards for its Identity & Access Management solution, including recognition from the prestigious SC Awards Europe 2018.

At the SC Awards Europe, My1Login scooped an award in the Best Identity Management Solution category, and were finalists in the Best Cloud Computing Security Solution.

My1Login also won the Identity & Access Management Solution of the Year at the Computing Security Awards, and were a finalist for the Security Excellence IAM Award. The IAM Award recognises that Identity and Access Management is of critical importance to networks forever under attack in a world increasingly dependent on digital profiles to protect data, and that regulatory compliance is an extremely important factor in a good IAM solution.

These successes follow on from My1Login’s win in at last year’s International Contribution to Cyber Security at the SBRC Awards.

Jamie Andrew, Chairman of TRICAPITAL said: ‘We are delighted at this continuing recognition for the work of My1Login. Online security is an ongoing challenge for businesses and individuals alike, and we look forward to following the progress of the company as the team continue on their journey in this cutting-edge industry.’

Voting is underway for the Computing Security Awards 2018, and My1Login are hoping to retain their title of Identity & Access Management Solution of The Year.  If you’d like to vote, head to the CSS award website.  The last day for voting is October 1. 

Who are My1Login?

My1Login is the UK’s most secure, most widely-compatible, award-winning enterprise Identity & Access Management solution which enables organisations to mitigate password-related cyber-security risks, control user identities and help meet critical compliance obligations such as GDPR.

My1Login’s Single Sign-On solution integrates with all app types – web apps, mobile apps, flash apps, virtualised apps, and even legacy, thick-client apps and mainframes.

 


Read the story on the My1Login news blog.

For more information about the company, visit the My1Login website.

JOB OPPORTUNITY: Aurum Biosciences seeks Executive Chair

NHS Scotland spin-out company Aurum Biosciences is seeking to appoint a new Chair as the company enters an exciting new stage in its development.

Aurum is gearing up to start its first phase 2 study in the treatment of acute ischaemic stroke patients with its lead product ABL-101, which was discovered from technology coming out of the NHS. A major advance in Aurum’s manufacturing strategy is underway, and the company is also seeking corporate partnerships, and is in the process of raising new investment to fund the next studies on this condition.

Business angel syndicate TRICAPITAL led the initial funding round in 2015, bringing together private investment from the UK and USA, alongside Scottish Enterprise’s Scottish Investment Bank and The Wellcome Trust. During the last 3 years, the company has made major advances under the current leadership, and is now looking to strengthen the team with the appointment of a new Chair.

Aurum Executive Chair profile

The ideal candidate will have the following profile:

  • At least 15 years in senior management positions within pharmaceutical and/or biotechnology companies
  • At least one previous private equity-backed Board leadership position
  • Proven commercial and product development success
  • Experience of raising venture capital or other types of private investment
  • Experience and proven success in negotiating licensing deals between pharma/biotech companies for novel pharmaceutical products
  • Excellent contacts within the global pharma/biotech fields
  • An understanding of the economic drivers of biotech firms and an appreciation of the typical finances of such companies
  • A first degree in a scientific discipline, most likely a biological or medical degree, would be an advantage, as would a background in or knowledge of neurology.

An appropriate incentive arrangement will be agreed with the successful candidate.

How to apply

Please apply to Jim McGuire (CEO) at jmcguire@aurumbiosciences.com, enclosing CV and covering letter explaining your interest in and suitability for the role.

To find out more about this exciting company and ABL-101, visit the Aurum Biosciences website.

Watch this video for an overview of Aurum Biosciences and ABL-101:

TRICAPITAL welcomes Ryboquin acquisition of Nanogenics

TRICAPITAL has welcomed investee Ryobquin’s acquisition of gene therapy pioneers Nanogenics Limited. Ryboquin raised £4.45 million in its third funding round from new and existing share-holders to acquire Nanogenic Solutions.

TRICAPITAL chairman Jamie Andrew said: “I’m delighted that TRICAPITAL has been able to support the acquisition of Nanogenics by Ryboquin. As Borders business angels, we’re especially pleased to support Selkirk-based Ryboquin in this significant phase of its journey, and look forward to following the progress of the new combined company.”
The combined biotech company, Nanogenics, is set to revolutionise gene therapy by pioneering the safe, efficacious and regular dosing of all forms of gene therapy.

Nanogenics is tackling one of the greatest technical challenges in modern medicine: how to deliver gene therapy into target cells efficiently, and with minimal side effects. This problem has been holding back the true potential of gene therapy. The current approach is to use viruses and liposomes, which have limited applications, severe side-effects and expensive technical problems.
Nanogenics is developing LipTide™, an artificial virus which acts as a custom-built delivery system that can be modified to target different cell types and deliver different payloads, making the promise of gene therapy one step closer to reality.

LipTide™ is a protein-based nanoparticle which mimics natural viruses, but by-passes the many problems of viral delivery. The ability to regularly dose gene therapy payloads with LipTide™ could revolutionise the approach to gene therapy.

Dr Alan Walker, Chief Executive Officer, Nanogenics, says: “I am thrilled we have been able to combine these two businesses. It will offer real hope to those millions of patients living with diseases who have been unable to benefit from the advances in gene therapy because, until now, it has been so difficult to safely deliver the correct gene therapy to the right target. That can now change and we are already working with six major BioTech companies who want to access this exciting delivery mechanism.”

In addition to working with partners to deliver their gene therapy programmes, Nanogenics is developing its own product pipeline taking advantage of the revolutionary LipTide delivery platform. The lead programme, LipTide-ECP102, on which Nanogenics has US and EU patents, dramatically enhances chemotherapy and radiotherapy. A clinical trial is planned at the Christie Hospital Manchester in 2020. Currently LipTide-ECP102 is being scaled up to an industrial batch in collaboration with Strathclyde University.

Paul Murray, Executive Chairman, of the enlarged company, says: “We have worked hard and convinced investors of the huge potential of LipTide™ and we plan to grow the company quickly to a stage where we can take it public as soon as that is feasible. This is a great opportunity to generate real value by offsetting the high risk high return of product development with the amazing potential for multiple licence deals for the revolutionary LipTide™ platform. It is very rewarding to be involved in the cutting edge of medical science.”

ENDS

To find out more about the company’s pioneering work and the LipTide™ artificial virus, visit the Nanogenics website.

Ryboquin acquires gene therapy pioneers Nanogenics

TRICAPITAL investee Ryboquin has been hitting the headlines after its recent acquisition of gene therapy pioneers Nanogenics. The new combined company, Nanogenics Ltd, is set to revolutionise gene therapy by pioneering the safe, efficacious and regular dosing of all forms of gene therapy.

Nanogenics is developing LipTide™, an artificial virus. Currently viruses and liposomes are used, which have limited applications, severe side-effects and expensive technical problems.

Here’s some of the press coverage:

Herald: Selkirk-based biotech firm Ryboquin acquires Nanogenic Solutions to advance gene therapy

BBC: Selkirk-based Ryboquin completes company acquisition

Daily Business Group: Borders drugs firm plans IPO after £4.45m acquisition

Press: Blue Square investment featured in Newcastle Journal

Newcastle company Blue Square hit the news after the £500k investment led by TRICAPITAL.  Click to see a feature on Blue Square in Newcastle’s The Journal.

And here’s more about Blue Square’s training of 100 new smart meter apprentices at St Helen’s College.

Meet the Smart Meter Training Academy.

Exterity Video System a Winner at Paris Longchamp Hippodrome

Exterity’s video signage is bringing visitors right into the action at the iconic Paris Longchamp Hippodrome. The Edinburgh-based TRICAPITAL investee now has 150 digital displays across the horseracing venue, giving guests a more exciting and immersive experience at the races.

Here’s the detail from Exterity:

Exterity today announced that Hippodrome ParisLongchamp has deployed its solutions for IP video and digital signage across the 57-hectare horse racing facility to enable guests to enjoy a more immersive experience at the races.

Following a €140 million investment and 2 years of refurbishment, the newly renamed ParisLongchamp has regained its historic status and recognition as a modern, elegant and fashionable new Parisian destination. Yet, the horseracing venue, nestled in the heart of the Bois de Boulogne, has decided to break with the classic codes of traditional racecourses and open up its grounds to the general public. A new 160-metre-long grandstand, topped with a glass building that plays with transparency and perspectives; guests gain a breathtaking view, taking in the course, the parade ring and the stables.

Integral to this new image, ParisLongchamp deployed an Exterity IP video system that incorporates 500 screens, providing both video and digital signage for race fans, and in support of the wide range of corporate events hosted across the 55,000 sq. metres of public enclosures. The Exterity system offers high-resolution live and recorded video plus signage across twenty different spaces, which are modular and fully equipped to welcome between 500 and 60,000 people, creating a veritable conference centre.

“Horseracing is no longer a specialist interest, and we needed a system that guaranteed a tailored experience for professionals and first timers plus our corporate hospitality clients,” said Thierry Migeon, Technical Manager at France Galop, the governing body of flat and steeplechase horse racing in France. “Today, we offer our own internally produced content, dedicated channels for professionals, betting information for speculators, and content live-streamed from rooms that are normally not accessible to the general public, such as the jockey weighing room and the stables. This unusual experience enables us to transform the perception of a day at the races, and we are already identifying new ways to expand on the Exterity system for guests during the Qatar Prix de l’Arc de Triomphe in October.”

Installed by system integrator Manganelli Technology, the Exterity system includes a full end-to-end IP video installation spanning 500 screens and offering a range of specialist TV channels, including At the Races, Equidia Pro and Racing UK, alongside the digital terrestrial television (TNT) service and encrypted channels, such as BeIn Sport and Canal Plus Sport. To enable the distribution of premium, encrypted channels in specific areas, the system is also fitted with content protection solutions, including Conditional Access by Conax and Viaccess Orca, as well as Samsung LYNKTM DRM.

Exterity ArtioSign digital signage enables France Galop to deliver information, merchandising and pricing via 150 TV displays across the hospitality suites, public spaces and on-site refreshment areas. The system also provides France Galop with the ability to deliver content to visitors’ mobile devices via a web app, including replays of the races.

“We originally worked with Exterity when we deployed the IP video system at Stade Pierre Mauroy for the UEFA Euro 2016, and they were an obvious choice for such a large-scale, international venue as the Hippodrome ParisLongchamp,” said Fabrice Leguay, Regional Director at Manganelli Technology. “ParisLongchamp is a very sophisticated venue with an extensive master control room that centrally manages internal, national and international TV signals to deliver personalised content to visitors across the venue. This type of installation means that we need to work with trusted, reliable, high-calibre IP video products, which is why we chose Exterity. Being able to combine the wide array of TV channels with built-in digital signage and content protection licenses for international premium TV channels also made a huge difference, and enabled us to deploy the system in record timeframes without compromising on anything.”

“ParisLongchamp is an iconic venue, not only for horseracing fans, but also for international visitors to Paris, and we are proud to play an active part in this new, tech-savvy venue,” said said Myriam Calaber, Europe & Mediterranean Sales Director at Exterity. “With over 500 screens and between 50 and 60 channels playing at all times, it is an incredible feat of video and digital signage, and showcases a unique blend of interactive solutions for guest engagement.”

Exterity’s IP video and digital signage systems are in use at a number of stadiums and venues around the world, including 4 out of 10 stadiums that hosted the 2016 UEFA Euros, including Stade Pierre Mauroy and the Stade Vélodrome, as well as Matmut Stadium de Gerland and Stade Océane (France); Celtic Park Stadium, Emirates Arena, Lord’s Cricket Ground, The Open golf championship, Glamorgan County Cricket Club, Goodwood, Ulster Rugby stadium and Sandown Park (UK); The Hazza bin Zayed Stadium (استاد هزاع بن زايد‎‎) and King Abdullah Sports City (مدينة الملك عبدالله الرياضية) in the Middle East; PSV Eindhoven (The Netherlands); RDC Espanyol de Barcelona (Spain); Riverside Stables, Rosehill Racecourse and the Royal Randwick Racecourse (Australia); SV Sandhausen and TSG 1899 Hoffenheim (Germany); and many more.
###
ABOUT EXTERITY: Since 2001, Exterity has been designing, developing and manufacturing technically innovative products that deliver networked video and digital signage over IP to some of the leading organizations across the globe. Exterity solutions enable the distribution of HD quality TV and video over enterprise IP networks to an unlimited number of end points, supporting large volumes of content and receiving devices without compromising system performance or availability.
Highlights:
• Deployed in over 40 countries
• Robust, scalable IPTV and digital signage solutions for organisations of any size and across any sector
• Unique industry-leading features and market specific application
Headquartered in Scotland UK, we extend our global reach through our offices in New York, Dallas, London, Paris, Sydney, Dubai, Singapore, Hong Kong and Johannesburg. Localised knowledge and expertise is enhanced through the Exterity StreamForce program of credible, technically innovative partners, plus an extensive network of in-country resellers and distributors.

Released: Edinburgh, Scotland/Reims, France – 7 June 2018

Findra in Scotland on Sunday

tricapital-findra-press-scotland-on-sundayFINDRA in Scotland on Sunday! News of the Borders-based sports clothing company’s new shop in Edinburgh, and growth plans after £250k investment by members of TRICAPITAL and other investment syndicates.

Wishing FINDRA and the team well on their plans for the Edinburgh shop and beyond.

Click right to read the Scotland on Sunday article [2MB file] or pick it up here: FINDRA TRICAPITAL article

Video: Exterity Avedia and 4k Media player at NEC

Fiona Bayle from TRICAPITAL investee Exterity showcases the new Avedia and 4K media players at NEC.

Find out more about Avedia media players on the Exterity website.

Interested in investing in high-growth tech companies? Here’s our introduction for business angels and a look at the TRICAPITAL portfolio of companies that members have invested in.

Want to find out more? Get in touch!

Click to play the video:

 

TRICAPITAL leads £500,000 investment in Blue Square smart meter company

blue-square utilities smart meter tricapital TRICAPITAL has led a £500,000 investment in Newcastle smart meter specialists Blue Square Utilities. The dual fuel smart meter installers are the newest addition to TRICAPITAL’s portfolio of 25 companies in sectors ranging from software, biomedical and engineering to textiles.

Blue Square Utilities currently employs 65 smart meter engineers working across the North of England on three utility contracts.

The company’s planned growth over the next two years is in line with the UK Government’s ‘Smart Meter Rollout’. Blue Square will be expanding its installs across the UK, subsequently building a workforce of over 300 engineers, including 100 apprenticeships.

The ‘Smart Meter Rollout’ is a nation-wide initiative to install approximately 53 million smart meters in over 30 million residential and commercial premises across the UK by the end of 2020. The rollout is part of the UK Government’s campaign to improve the management of energy across Scotland, England and Wales.

blue-square utilities tricapitalTim Cantle-Jones, CEO of Blue Square Utilities, said: “With the support of investors, we have been able to secure contracts and recruit a skilled workforce, with a view to achieving sustained profitable growth. The smart meter roll out represents a huge opportunity for a business such as ours to become established as a key national player in the energy infrastructure sector.”

Jamie Andrew, Chairman of TRICAPITAL Ltd, said: “We are delighted to have led this investment round to provide the funding to underpin Blue Square’s growth ambitions. We have been impressed with Tim Cantle-Jones’s vision for the company and the benefits the company brings to the wider community through its smart meter installation service. We wish Tim and his team every success in executing his growth plan.”

Moray Martin, Chairman of Blue Square Utilities and TRICAPITAL Director, said: “Importantly, Blue Square Utilities is creating new jobs, and a lot of them. A number of significant long term contracts have already been completed, providing the company with secure long term recurring revenue, immediate profitability and a healthy cash flow position – all in line with the promises we made to our investors. The company is surrounded by opportunities and we are already considering how we may be able to accelerate growth to accommodate them.”

About Blue Square Utilities

Blue Square Utilities is an independent smart meter installation business servicing small-medium sized energy suppliers throughout the UK. Its scope extends to the installation and maintenance of legacy and commercial metering services.

The team has extensive experience in the smart metering rollout, offering an end-to-end dual fuel Smart Meter Installation Solution.

Blue Square engineers are fully qualified dual fuel smart meter installers registered with Energy & Utility Skills.

For more information on the UK Government’s Smart Meter Rollout, visit: https://www.smartenergygb.org/en/smart-future/about-the-rollout

Visit the Blue Square Utilities website.

Image with kind permission from Blue Square Utilities: Catherine Armstrong (Company Secretary), Moray Martin (Chair), Tim Cantle-Jones (CEO), Neil Kirkby (Operations Director).